Argentinian multicenter study on urinary tract infections due to Streptococcus agalactiae in adult patients

Authors

  • Laura Vigliarolo Cátedra de Microbiología Clínica, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, La Plata. Provincia de Buenos Aires, Argentina
  • Barbara Arias Departamento de Microbiología, Inmunología, Biotecnología y Genética. Cátedra de Microbiología. Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Ciudad Autónoma de Buenos Aires, Argentina
  • Mariana Suárez Cátedra de Microbiología Clínica, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, La Plata. Provincia de Buenos Aires, Argentina
  • Evert van Haute Departamento de Microbiología, Inmunología, Biotecnología y Genética. Cátedra de Microbiología. Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Ciudad Autónoma de Buenos Aires, Argentina
  • Verónica Kovacec Departamento de Microbiología, Inmunología, Biotecnología y Genética. Cátedra de Microbiología. Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Ciudad Autónoma de Buenos Aires, Argentina
  • Horacio Lopardo Departamento de Microbiología, Inmunología, Biotecnología y Genética. Cátedra de Microbiología. Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Ciudad Autónoma de Buenos Aires, Argentina
  • Laura Bonofiglio Departamento de Microbiología, Inmunología, Biotecnología y Genética. Cátedra de Microbiología. Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Ciudad Autónoma de Buenos Aires, Argentina
  • Marta Mollerach Departamento de Microbiología, Inmunología, Biotecnología y Genética. Cátedra de Microbiología. Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Ciudad Autónoma de Buenos Aires, Argentina

DOI:

https://doi.org/10.3855/jidc.10503

Keywords:

Urinary tract infections, Streptococcus agalactiae, group B, Argentina

Abstract

Introduction: Streptococcus agalactiae (group B streptococcus, GBS) is a recognized urinary pathogen both in males and pregnant or non-pregnant women. Data regarding GBS serotypes recovered from urinary tract infections (UTIs) are scarce. The aim of this study was to describe the clinical and microbiological characteristics of UTIs caused by GBS in adult patients in Argentina.

Methodology: A prospective multicenter study involving 86 centers was conducted in Argentina between July 1st, 2014 and June 30th, 2015. Antimicrobial susceptibility and serotype distribution of GBS isolated from the urinary tract of adult patients were determined. Susceptibility tests were performed by the disk diffusion and/or agar dilution methods. Epidemiological and clinical characteristics of the patients were considered to identify associated comorbilities.

Results: Seven hundred and one GBS were sent to the reference laboratory in the above mentioned period, however, only 211 fulfilled our selection criteria (demographic data availability, underlying diseases reported, colony counts greater than 105 CFU/mL, single organism isolated from the urine sample). No penicillin-resistant GBS was found but fluoroquinolone resistance was high (12.8%), especially among GBS isolated from men and non-pregnant women. UTIs due to GBS were associated to underlying diseases in men and non-pregnant women, particularly diabetes mellitus. Most of the isolates showed serotypes Ia and III.

Conclusions: GBS are still susceptible to penicillin but fluoroquinolone resistance is a growing concern, at least in Argentina. There are underlying conditions that could be associated to urinary infections caused by GBS.

Downloads

Published

2019-01-31

How to Cite

1.
Vigliarolo L, Arias B, Suárez M, van Haute E, Kovacec V, Lopardo H, Bonofiglio L, Mollerach M (2019) Argentinian multicenter study on urinary tract infections due to Streptococcus agalactiae in adult patients. J Infect Dev Ctries 13:77–82. doi: 10.3855/jidc.10503

Issue

Vol. 13 No. 01: January 2019

Section

Brief Original Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Crossref
Scopus
Google Scholar
Europe PMC